BBOT Competitors & Alternatives
Compare BridgeBio Oncology Therapeutics, Inc. with similar stocks in the same industry
Biotechnology
BBOT
Main Stock$2.35
Tradestie Score
49
Market Cap
$952.74M
P/E Ratio
4.8
Analyst Upside
+878.7%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NGNE
Neurogene, Inc. Common Stock
|
$23.90
|
$256.54M | - | 30 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$19.80
|
$240.89M | - | 42 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$4.95
|
$231.77M | - | 42 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$10.93
|
$227.00M | - | 42 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$8.03
|
$211.22M | - | 60 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.00
|
$202.58M | - | 36 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$14.37
|
$199.71M | - | 51 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.78
|
$158.43M | - | 56 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.23
|
$154.27M | - | 41 | Compare |
More BBOT Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry